Taboola script Diabled on 7th April on request Adpushup head code Diabled on 7th April on request
Booster doses are administered to a vaccinated population that has completed a primary vaccination series (currently one or two doses of COVID-19 vaccine depending on the product) when, with time, the immunity and clinical protection has fallen below a rate deemed sufficient in that population.
WHO with support of the Strategic Advisory Group of Experts (SAGE) on immunization and its COVID-19 Vaccines Working Group, is reviewing the emerging evidence on the need for and timing of an additional vaccine dose for the currently available COVID-19 vaccines which have received Emergency Use Listing.
Introducing booster dose should be firmly evidence-driven and targeted to the population groups in greatest need
The rationale for implementing booster dose should be guided by evidence on waning vaccine effectiveness, in particular a decline in protection against severe disease in the general population or in a high-risk population, or due to VOC.
To whom it should be given
- Sr. Consultant Physician, Kamineni Hospitals, Hyderabad